Recent Material Events - Ligand Pharm (LGND)

Filing Date	Description
2008-09-26	In accordance with the terms of the Merger Agreement, the parties approved the form of a Contingent Value Rights Agreement, attached hereto as Exhibit 10.1, to be entered into by and among Ligand, Pharmacopeia and a rights agent at the closing of the ...
2008-09-25	Attached as Exhibit 99.1 is a transcript of a conference call hosted by Ligand Pharmaceuticals Incorporated (“ Ligand ”) and Pharmacopeia, Inc. (“ Pharmacopeia ”) on Wednesday, September 24, 2008 at 5:30 pm EDT to discuss the prop ...
2008-09-24	On September 24, 2008, Ligand Pharmaceuticals Incorporated (the “ Company ” or “ Ligand ”) entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), with Pharmacopeia, Inc., a Delaware corporation ...
2008-09-05	The information contained in Item 1.01 of this Current Report on Form 8-K with respect to the Settlement Agreement is incorporated by reference herein and made a part hereof. ...
2007-12-19	Ligand Pharmaceuticals Incorporated (the “Company”) entered into a sublease agreement (the “Sublease Agreement”) with eBIOSCIENCE, INC. (the “Subtenant”) which became effective on December 13, 2007, upon receipt of conse ...
2007-12-06	Material event, click here to read
2007-03-15	Material event, click here to read
2007-03-05	Material event, click here to read
2007-02-28	Material event, click here to read
2007-02-06	On January 31, 2007, the Company announced a plan of termination with respect to certain of its employees in connection with its completed and pending asset sales previously announced in September 2006. Under the plan of termination the Company is re... ...